Financials

  • Market Capitalization 97.91 M
  • Employee 112
  • Founded 1999
  • CEO Jacqueline Shea
  • Website www.inovio.com
  • Headquarter Delaware, United States
  • FIGI BBG000BK6YX5
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.96
Price to sales ratio
1 248.52

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3977
ICCC
ImmuCell Corporation - Common Stock
11.90 USD+7.40%+13.44%+24.09%+83.93%107.66 M USD
3991
VRCA
Verrica Pharmaceuticals Inc. - Common Stock
6.04 USD+2.03%-1.47%+4.14%+0.33%103.76 M USD
4005
ENLV
Enlivex Ltd. - Ordinary Shares
6.23 USD-6.60%+1146.00%+777.46%+394.44%98.59 M USD
4007
BMEA
Biomea Fusion, Inc. - Common Stock
1.31 USD-1.50%-7.09%+9.17%-32.82%94.71 M USD

Frequently asked questions about Inovio Pharmaceuticals, Inc. - Common Stock

What is the Inovio Pharmaceuticals, Inc. - Common Stock stock price today?

The current price of Inovio Pharmaceuticals, Inc. - Common Stock (INO) is 1.19. Over the past 24 hours, the stock has changed by +2.59%. Follow the INO chart for real-time price dynamics.

What is the stock ticker of Inovio Pharmaceuticals, Inc. - Common Stock?

Inovio Pharmaceuticals, Inc. - Common Stock trades under the ticker INO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Inovio Pharmaceuticals, Inc. - Common Stock stock going up?

INO has changed by +1.71% over the last week, +6.25% over the last month, and -13.14% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Inovio Pharmaceuticals, Inc. - Common Stock net income for the last quarter?

Inovio Pharmaceuticals, Inc. - Common Stock reported net income of -19.68 M for the last quarter. The previous quarter showed 3.76 M, which means net income changed by -622.80%.

How many employees does Inovio Pharmaceuticals, Inc. - Common Stock have?

As of the latest available data, Inovio Pharmaceuticals, Inc. - Common Stock has 112 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Inovio Pharmaceuticals, Inc. - Common Stock stock?

You can buy Inovio Pharmaceuticals, Inc. - Common Stock (INO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Inovio Pharmaceuticals, Inc. - Common Stock stock?

Investing in Inovio Pharmaceuticals, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the INO chart and related analysis on metatrader.com as part of your research.

Inovio Pharmaceuticals, Inc. - Common Stock

Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development.

News